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Abstract 
 
Here, the new biosensor destined for screening of interactions between kinase JAK2 and compounds 
which may act as inhibitors was presented. The Cu(II) complex of pentetic acid thiol ligand was applied 
for immobilization of kinase JAK2 on the gold electrode surface through his-tagged chemistry. The base 
of the biosensor response was the change of the electrochemical properties of the Cu(II) redox centres 
upon formation of the kinase JAK2–potential inhibitor complex. The increasing inhibitor concentration 
caused the decrease of reduction/oxidation Cu(II) current observed with Osteryoung square wave 
voltammetry. The biosensor usability was checked using known inhibitors, berberines–isoquinolone 
alkaloids, as well as caffeic acid—a control compound which has no affinity to kinase JAK2. The 
possible parameters suitable for estimation of the strength of the interactions between kinase JAK2 
covalently attached to the Cu(II) complex of pentetic acid thiol ligand deposited on the gold electrode 
surface and potential inhibitors present in the solution were presented. 
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1. Introduction 
 
Janus kinases (JAKs), discovered in the early 1990s, are important non-receptor protein tyrosine 
kinases (PTKs). In mammals, the JAK family comprises four members: JAK1, JAK2, JAK3 and TYK2, 
which are crucial for cytokine, growth factor and interferon signaling pathways.  
The JAK autophosphorylation induces a conformational change within itself, enabling it to 
transduce the intracellular signal by further phosphorylating and activating transcription factors called 
STATs (signal transducer and activator of transcription) [1–3].  
Disorders of signaling pathways JAK/STAT may cause activity increase of STAT proteins 
observed in a number of autoimmune and cancer diseases [4,5]. Therefore, there is a great interest in 
searching for new kinase JAK inhibitors, which might be applied in molecular therapy. 
The most commonly used tools to perform kinase activity screening are radioisotope methods 
[6], phosphor-specific antibodies [7,8], surface plasmon resonance [9–11], fluorescence resonance 
energy transfer-based systems [12,13] and mass spectrometry [14,15]. The main drawbacks of these 
techniques are high cost, consumption of large amount of precious biological materials and long time of 
analysis. One of possible alternative strategy is the use of biosensors. They demand only very small 
amounts of analyzing materials, which decrease the cost of study. The growing interest of biosensor 
developments is well documented in numerous articles [16–19]. The electrochemical approaches 
destined for detection of protein phosphorylation and to assay the kinase activity have been developed 
by Li and co-workers. In general, their analytical strategy is based on substrate – product – electroactive 
markers electrostatic interactions. The enzyme-linked electrochemical strategy based on biotin labelled 
anti-phosphoserine and Au-nanoparticles loaded with HRP modified streptavidin have been successfully 
applied for study kinase inhibition behaviour of ellagic acid [20]. The very sensitive detection of protein 
phosphorylation was achieved by Zr
+4
 linkage between the phosphorylated peptide and DNA probe. The 
electrostatic interactions between long DNA strand and [Ru(NH3)6]
3+
 strongly amplified the signal [21]. 
The charged difference of substrate peptide monolayer deposited on the electrode before and after 
phosphorylation recorded in the presence of positively charged redox marker is a base of switchable 
―on–off‖ electrochemical biosensors for screening kinase activity as well as its inhibition [22]. 
Polyethylene glycol (PEG) was suitable material for kinase protein entrapping. In this case, the 
interactions between kinase protein entrapped on PEG modified electrode and cAMP present in the 
solution was observed in the presence of negatively charged redox marker Fe(CN)6
-3/-4
 [23]. 
Here, proposed the new biosensor incorporated covalently attached on the electrode surface 
kinase JAK2 destined for exploring its interaction with potential inhibitors.  
One of crucial parameter for biosensor fabrication is proper proteins immobilization on the solid 
surface of electrodes assuring their biological activity. The use of His-tag chemistry might secure this 
demand [24–26]. The most popular system for oriented immobilization of histidine-tagged proteins are 
complexes of transition metal ions (Cu
2+
, Ni
2+
, Zn
2+
, Co
2+
) with ethylenediamine tetraacetic acid 
(EDTA), nitrilotriacetic acid (NTA) or iminodiacetic acid (IDA) [27–36].  
The pentetic acid (diethylene triamine pentaacetic acid—abbreviation DTPA), polyamino 
carboxylic acid consisting of a diethylenetriamine backbone with five carboxymethyl groups, having 
high affinity for metal cations might be an alternative ligand. The formation constants for its complexes 
are about 100 greater than those for EDTA [37]. DPTA binds copper(II) in a hexadentate manner 
utilizing the three amine centres and three of the five carboxylates [38]. Molecular model computations 
based on CSChem-3D MOPAC, as well as spectral and thermogravimetric methods concerning homo-
dinuclear complexes of transition metal cations with dianionic ligand [H3DTPA]
-2
 showed a 
hexacoordinate distorted octahedral environment around the metal ion [39]. The authors proved the 
presence of six coordinated water molecules, which might be replaced by other ligands. Cyclic 
voltammetry performed for [Cu2(H3DTPA)(H2O)6]Cl2
2+
 present in the solution showed a quasi 
reversible Cu II/I redox couple at the potential +0.04 V and -0.11 V, which is very suitable for sensor 
applications. 
Therefore, in the study presented a Cu(II) complex with DPTA was applied for immobilization 
of kinase JAK2 on the gold electrode surface through his-tagged chemistry. The DPTA-Cu(II) complex 
formed on the surface of gold electrodes plays the double role: immobilization as well as transducer 
sites.  
The biosensor proposed was used for electrochemical screening of interactions between JAK2 
and known kinase inhibitors, as well as berberines, which are isoquinolone alkaloids. Control 
measurements with caffeic acid, which has no affinity to kinase JAK2 were also performed. 
 
 
 
 
2. Materials and methods 
 
 
2.1. Chemicals and reagents 
 
Pentetic acid (DPTA) thiol ligand, palmatine and 13-benzylpalmatine were synthetized at the 
Chemistry Department of KU Leuven, Belgium. Trisma hydrochloride, glycerol, copper (II) acetate, N-
acetylcysteamine (NAC), potassium chloride, sodium chloride, chloroform, sodium perchlorate, 
commercial inhibitors: tyrphostin AG-490 – (2E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)-
acrylamide and caffeic acid (3,4-dihydroxycinnamic acid), DDM were purchased from Sigma-Aldrich 
(Poznań, Poland). Other commercial inhibitors: Tasocitinib, K252a, Fasudil (1-(5-isoquinolinesulfonyl)-
homopiperazine), Erlotinib (N-(3-ethylenephenyl)-6,7-bis(2-methoxy-ethoxy)quinazolin-4-amine) were 
purchased from LC Laboratories (Canada). Potassium hydroxide, sodium hydroxide, sulfuric acid, 
sodium sulfate, cesium chloride, methanol and ethanol were purchased from POCH (Gliwice, Poland). 
Thesit was purchased from Fluka (Sigma-Aldrich, Poznań, Poland) and CHAPS, Tween-20 were 
purchased from BioShop (Lab Empire, Rzeszów, Poland). High purity water, resistivity 18.2 MΩcm 
(Millipore) was used for all experiments. 
 
 
2.2. Janus kinase 2 (rGST-His6-JAK2) preparation 
 
The kinase domain of JAK2 (JH1) was expressed in baculovirus expression system Bac-to-Bac 
in HF insect cells (Invitrogen). The protein coding sequence was cloned into the plasmid pFastBac 
HT(Invitrogen) in frame with glutathione S-transferase (GST), S- and hexahistidine-tag (His6) 
sequences. Subsequently, the whole cassette was introduced into the bacmid DNA. Transfection of Sf21 
cells with recombinant bacmid, propagation of recombinant baculovirus in Sf21 cells and infection of 
HF cells were all carried out according to the Invitrogen’s manual.  
The recombinant JAK2 (rGST-His6-JAK2) was purified from HF insect cells lysates applying 
two-step affinity chromatography on Ni-NTA-agarose and glutathione-agarose.  
HF cells were lysed by freeze–thaw cycles in the lysis buffer: 50 mM Tris–HCl pH 8.0, 0.5 M 
NaCl, 1% Tween 20, 1 mM DTT, 10% glycerol, 10 mM imidazole, containing a proteinase inhibitors 
cocktail (Roche). The lysate was clarified (50,000g, 60 min, 4.C) and the supernatant was adsorbed onto 
Ni-NTA agarose. The resin was washed with the buffer: 50 mM Tris–HCl, pH 8.0, 0.5 M NaCl, 1% 
Tween 20, 10% glycerol, 10 mM imidazole and the proteins were eluted with the elution buffer (wash 
buffer containing 0.25 M imidazole). Eluent was diluted two-fold with the wash buffer and incubated 
with the GSH-agarose beads (Sigma-Aldrich) for 2 h at 4 °C. After washing out unadsorbed 
contaminants from the beads, the adsorbed protein was eluted with dialysis buffer containing10 mM 
reduced glutathione (Sigma-Aldrich). Collected fractions were dialysed against 25 mM Tris–Cl pH 8.0, 
0.1 M NaCl, 0.05% Tween 20, 1 mM DTT, 10% glycerol and then concentrated on Microcon filters 
(MWCO 50 kDa, Millipore), aliquoted and kept frozen at -80 °C.  
The applied procedure allowed to obtain the recombinant JAK2 (rGST-His6-JAK2) of high 
purity as judged by SDS PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) [40] and 
Western blotting using a mouse monoclonal [HIS-1] to 6X His tag alkaline phosphatase-conjugated 
antibody (Abcam).  
The protein concentration was determined using the Protein Assay kit (Bio-Rad) with bovine 
serum albumin (BSA) as a standard. 
 
 
2.3. Successive steps of biosensor preparation 
 
The biosensor preparation was illustrated in Fig. 1. Gold disk electrodes with 2 mm
2
 nominal 
area (Bioanalytical Systems (BAS), West Lafayette, IN) were used for experiments. The electrodes were 
polished with wet 0.3 m and 0.05 m alumina slurry (Alpha and Gamma Micropolish, Buehler, Lake 
Bluff, IL, USA) on a flat pad for 5 min each and rinsed repeatedly with Milli-Q water. Electrochemical 
cleaning was performed in 0.5 M KOH using CV technique with a three-electrode configuration. 
Measuring conditions were as follows: minimum potential -1.2 V, maximum potential -0.4 V, scan rate 
100 mV s
-1
, number of cycles: 3, 50 and 10. After finishing electrochemical cleaning, each electrode was 
washed with Milli-Q water and placed in water (for several minutes, until the next step) to avoid 
contaminants from air. Next, the electrodes were cleaned in 0.5 M H2SO4 by scanning in the potential 
window: from -0.3 V to 1.5 V, number of cycles: 3, 10 and 3.  
Clean electrodes were immersed in solution of 1.0 × 10-5 M DPTA and 1.0 × 10-3 M NAC in an 
ethanol/water mixture (80/20, v/v) at the room temperature for 3 h. The modification solutions were put 
into the tubes. After dipping the electrodes, the tubes were sealed with teflon tape and parafilm in order 
to avoid solvent evaporation. After modification, the electrodes were washed with an ethanol/water 
mixture (80/20, v/v) and a chloroform/methanol mixture (1/1, v/v) and were dipped in a copper(II) 
acetate solution in a chloroform/methanol mixture (1/1, v/v) at room temperature for 3 h. The 
modification was performed in the tubes sealed with teflon tape and parafilm. After modification, the 
electrodes were washed with the chloroform/methanol mixture, followed by methanol and finally Milli-
Q water.  
Directly after Cu(II) immobilization, 10 l droplets of 0.6 M rGST-His6-JAK2 solution (in 
buffer: 25 mM Tris–Cl, pH 8.0, 0.1 M NaCl, 0.05% Tween-20, 10% glycerol) were aliquoted onto the 
surface of each electrode. The tubes with electrodes were again sealed with eppendorf test-tube and 
parafilm and incubated 2 h at +4 °C. After incubation, the electrodes were washed and conditioned 
overnight in buffer (25 mM Tris–Cl, pH 8.0, 0.1 M NaCl, 10% glycerol) with 1% (v/v) of methanol. 
Next, the electrodes were washed with buffer and 0.1 M KCl aqueous solution, put into a measuring cell 
with 0.1 M KCl aqueous solution, and deoxygenated by purging with nitrogen for 15 min.  
After verifying the presence of rGST-His6-JAK2 protein on the surface of the gold electrode by 
CV and OSWV techniques, 10 l droplets of inhibitor solution (in buffer: 25 mM Tris–Cl, pH 8.0, 0.1 
M NaCl, 10% glycerol and 1% (v/v) of methanol) were deposited on the top of modified electrode 
surface. The electrodes were covered and incubated with a 10 l solution of the compounds studied for 
30 min at room temperature. Next, the electrodes were rinsed with buffer and 0.1 M KCl, transfered to 
the measuring cell containing 0.1 M KCl aqueous solution, and deoxygenated by purging with nitrogen 
for 15 min, in order to avoid the presence of oxygen during the electrochemical measurements. The 
potential was cycled from 700 mV to -300 mV with scan rate 100 mV s
-1
 for the CV measurements. 
OSWV was performed with potential from 700 mV to -300 mV with a step potential of 1 mV, a square 
wave frequency of 25 Hz, and amplitude of 50 mV. Each compound studied was examined in the 
concentration range from 0.05 M to 0.50 M.  
 
 
2.4. Electrochemical measurements  
 
All electrochemical measurements were performed on a potentiostat-galvanostat PGSTAT302N 
(Autolab, Eco Chemie, Netherlands) with a three-electrode configuration. Potentials were measured 
versus a Ag,AgCl|NaCl (3 M) reference electrode, a platinum wire served as an auxiliary electrode. The 
BAS gold electrodes were used as working electrodes. CV measurements with electrode incorporated 
NAC/DPTA-Cu(II)-rGST-His6-JAK2 SAM were performed in the presence of 0.1 M KCl, 0.1 M NaCl, 
0.1 M Na2SO4, 0.1 M NaClO4 and 0.1 M CsCl in order to select the best supporting electrolyte. 
Cyclic Voltammetry (CV), Osteryoung Square Wave Voltammetry (OSWV) and 
Electrochemical Impedance Spectroscopy (EIS) were performed in 0.1 M KCl or in 0.1 M KCl + 1 mM 
[Fe(CN)6]
3-/4-
. 
 
 
 
 
3. Results and discussion 
 
 
3.1. The electrochemical characterization of NAC/DPTA-Cu(II)-rGST-His6-JAK2 self-assembled 
monolayer  
 
The course of gold electrode modification was presented in Fig. 1. Each step of modification 
was monitored by cyclic voltammetry (Fig. 1 SI) and electrochemical impedance spectroscopy (Fig. 2 
SI).  
The bare gold electrode in 0.1 M KCl with 1 mM [Fe(CN)6]
3-/4-
 showed the reversible redox 
couple (Ep = 83 ± 4 mV) and almost a straight line in the Nyquist plot, which is characteristic for the 
diffusion-limiting step of the electrochemical process. The deposition of the NAC-DPTA SAM caused a 
decrease of reversibility(Ep = 280 ± 60 mV) and increased the electron transfer resistance to 144 ± 43 
kΩ. On the other hand, the complexation of Cu(II) by DPTA slightly improved the reversibility of the 
redox couple(Ep = 196 ± 34 mV) and decreased the electron transfer resistance to 44 ± 10 kΩ.  
In order to keep the right structure and activity of kinase rGST-His6-JAK2, the presence of 
detergent in the buffer solution is necessary. Thus, the influence of the following detergents on the 
stability of sensing monolayer deposited on gold electrode were tested: DDM, CHAPS, Thesis, Tween-
20, Triton X-100 (data not shown). Among them, Tween-20 displayed no effect. Thus, this detergent 
was used as the component of the immobilization buffer: 25 mM Tris–Cl, 0.1 M NaCl, 0.05% Tween-
20, 10% glycerol, pH 8.0. 
The immobilization of rGST-His6-JAK2 to Au-NAC-DPTA-Cu(II) SAM substantially 
decreased the reversibility of the system (Faradic current was not observed) and increased the electron 
transfer resistance up to 359 ± 112 kΩ. These results were in good agreement with those already 
reported for gold electrode incorporating His6-Rio1 protein [32].  
The rGST-His6-JAK2 deposition via coordination of a hexahistidine tag by DPTA-Cu(II) redox 
centres was also proved by cyclic voltammetry performed in 0.1 M KCl (Fig. 2). A 2 h incubation at 
room temperature NAC/DPTA-Cu(II)-electrodes with 10 l droplets of 0.6 M rGST-His6-JAK2 
solution in buffer deposited on the top of electrode was sufficient for protein immobilization. Even 
though the reversibility of the system decreased (Ep = 87 ± 34 mV), still the CuII/CuI redox couple 
was well recognized, with reduction and oxidation peaks at 0.247 ± 0.022 and 0.334 ± 0.023 mV (n = 
60), respectively. 
The immobilization of rGST-His6-JAK2 on the redox active layer was also controlled with 
OSWV (Fig. 3). The intensity of Cu(II) redox current for electrodes modified by NAC/DPTA-Cu(II) 
and NAC/DPTA-Cu(II)-rGST-His6-JAK2 were 2.56 ± 0.83 A (n = 48/60, reproducibility 80%) and 
1.46 ± 0.31 A (n = 78/115, reproducibility 68%). These data allow to estimate a decrease of the Cu(II) 
redox current upon rGST-His6-JAK2 immobilization at the 43% level. 
In order to check the influence of the supporting electrolyte on the electrochemical properties of 
gold electrodes incorporating a NAC/DPTA-Cu(II)-rGST-His6-JAK2 monolayer, CV measurements 
were performed in the presence of 0.1 M solution of: CsCl, KCl, NaCl, Na2SO4 and NaClO4. CV 
measurements at the scan rate from 10 mV s
-1
 up to 1000 mV s
-1
 were also performed (Fig. 4, Fig. 3 SI). 
The suitability of electrolytes was in the following order: 
CsCl ≥ KCl > NaCl > Na2SO4 ≥ NaClO4  
The best defined peaks of CuII/CuI were observed in the presence of CsCl. The plot of the 
anodic and cathodic peak currents versus scan rates showed a linear relationship up to 1000 mV s
-1
 (Fig. 
3A SI). This confirms that the observed redox activity comes from Cu(II) redox centres located on 
electrode surface. The electron transfer coefficients () and the electron transfer rate constants (k) were 
calculated based on the generally applicable Laviron’s equation [41] and collected in Table 1. The 
values of  measured in the presence of CsCl and KCl, 0.21 ± 0.08 and 0.19 ± 0.09, respectively, were 
lower than 0.5. This indicates that the energy activation for electron transfer is lower for reduction than 
for oxidation process [41]. The electron rate constant shows how the redox couple is kinetically facile. 
This means that the systems possessing a small value of k reach equilibrium slower than systems 
possessing a larger value of k [37]. The k values were 1.06 ± 0.33 s-1 and 1.36 ± 0.29 s-1 for CsCl and 
KCl, respectively (Table 1). 
The calculation of the  and k parameters was not possible when NaCl, Na2SO4 and NaClO4 
were applied as the supporting electrolyte. The reduction and oxidation peaks were wide and barely 
visible (Fig. 3B–D SI). The presence of cations can affect the redox activity of copper(II) in the SAM, 
with the peak current decreasing in the sequence: 
Cs
+
 > K
+
 > Na
+
  
So, it might be concluded that in the case of chloride salts, their suitability for getting the best 
redox parameters of NAC/DPTA-Cu(II)-rGST-His6-JAK2 SAM increases with an increase of the cation 
lipophilicity (Table 1, Fig. 4, Fig. 3A and B SI), which is consistent with the Hofmeister series [42]. A 
similar trend was observed for the electrochemical properties of cytochrome c studied in a range of 
different chloride salts [43]. The best Faradaic current was recorded in the presence of CsCl.  
Since the CuII/CuI couple involves the transfer of a single electron per molecule, the charge Q 
calculated based on the integration of the voltammetric peaks of the cyclic voltammograms recorded at a 
scan rate of 100 mV s
-1
 (Fig. 4, Fig. 3A SI) was used for obtaining the Cu(II) surface coverage values 
(Γ) according to the equation [37]: 
Γ = Q / nFA 
where A is the real surface area of gold electrode (0.032 cm
2
), F is the Faraday constant (96,485 °C), n is 
the numbers of electrons transferred (n = 1) and Γ is the surface coverage. The obtained value, in the 
range of 2.0 × 10-10 mol cm-2 (Table 1), was in a good agreement with those already reported for other 
redox active SAMs [36,44]. 
Based on the above results, for the next electrochemical measurements 0.1 M KCl solution was 
selected. The electrochemical parameters of NAC/DPTA-Cu(II)-rGST-His6-JAK2 SAM observed in its 
presence were sufficient and only a little worse in comparison to these obtained in the presence of CsCl. 
In addition, KCl is more suitable for keeping the biological activity of proteins in comparison to CsCl.  
 
 
3.2. Electrochemical exploration of the interactions between rGST-His6-JAK2 immobilized on the 
electrode surface via NAC/DPTA-Cu(II) complex and inhibitors present in the solution 
 
The biosensor proposed was used for electrochemical screening of interactions between JAK2 kinase 
and known inhibitors, potential inhibitors (berberines), as well as with caffeic acid, used as a control 
compound which has no affinity to JAK2 kinase. The berberines, a class of isoquinoline alkaloids, were 
selected for this study because of their wide potential therapeutic properties [45]. Their ability for 
inhibition of kinases catalytic activity has been also reported [46]. The chemical structures of all 
compounds studied are collected in Table 2. 
OSWV technique was chosen for exploring rGST-His6-JAK2–inhibitor interactions. This 
technique allows to reduce the capacitive current. The solutions of potential inhibitors were prepared in 
the concentration range from 0.05 M to 0.50 M. With the increasing concentration of compounds 
studied the Cu(II) redox peak current decreased. The representative OSWVs recorded in the presence of 
Erlotinib (the strongest known inhibitor), palmatine (an isoquinolone alkaloid potential inhibitor) and 
caffeic acid (control compound) were presented in Fig. 5.  
The linear relationships between the relative Cu(II) redox current decrease vs. concentration of 
the studied compound were observed in the range from 0.05 M to 0.20 M. In the range from 0.20 M 
to 0.50 M the signals were changed only a little (Fig. 6, Fig. 4SI). 
Therefore, the relative decrease of the Cu(II) current measured at the lowest concentration (0.05 
M), as well as at 0.20 M where some kind of ―breaking point‖ occurred were selected for estimation 
of the strength of the interaction. In addition, parameter b from the regression equations calculated for 
the 0.05 M to 0.20 M range, were taken into account (Table 2). These three parameters allow to 
arrange all compounds studied from the highest to the lowest values. The highest values indicated the 
strongest interactions, which were observed for know inhibitors Erlotinib and Fasudil [47,48]. Strong 
interaction between Erlotinib and rGST-His6-JAK2 can be explained by the existence in the structure of 
an inhibitor aniline-pyrimidine scaffold. These chemotypes are known as promising kinase inhibitors 
[49]. The values recorded for palmatine and Tyrphostin AG-490 a well know inhibitor[47], were 
comparable. This indicated that an isoquinolone alkaloid (palmatine) could be explored in the future as a 
potential kinase inhibitor, for example with using electrochemical approaches developed by Li and co-
workers destined for determination of kinase phosphorylation activity [20–23]. The presence of a 
methyl-benzene substitution in the 13-benzylpalmatine structure substantially decreased the strength of 
its interaction with rGST-His6-JAK2 (Table 2). We can underline, that for caffeic acid, the control 
compound, which has no affinity to kinase JAK2, very low values for all three proposed parameters 
were observed. This indicated that the analytical system based on NAC/DPTA-Cu(II)-rGST-His6-JAK2 
was selective, and therefore can be applied for screening compounds which might act as the potential 
kinase inhibitors. 
 
 
 
 
 
4. Conclusions 
 
The biosensor based on a NAC/DPTA-Cu(II)-rGST-His6-JAK2redox active layer was 
successfully applied for electrochemical screening of the interactions between rGST-His6-JAK2 protein 
and selected compounds. The DPTA-Cu(II) complex deposited onto the electrode surface plays a double 
role, both as units for immobilization of rGST-His6-JAK2, as well as transduction centres tracking the 
kinase-selected compound interactions. 
The proposed analytical tool was very sensitive. Analytical signals were observed in the 
concentration range from 0.05 M to 0.20 M. The strongest biosensor responses were observed in the 
presence of known kinase inhibitors. Caffeic acid, a control compound, which has no affinity to kinase 
JAK2, generated very low responses. These results confirmed selectivity of biosensor presented. The 
response of one of the new compounds tested, a berberine analogue (isoquinolone alkaloid) was 
comparable to the responses of Tyrphostin AG-490 kinase inhibitor. This indicates that this berberine 
derivative could be explored further as a naturally occurring potential kinase inhibitor. 
Taking into account the above parameters, the biosensor presented could be applied as a suitable 
analytical tool for screening new potential kinase inhibitors. 
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Table 1. The electron transfer coefficient α, the electron transfer rate constant k and surface coverage Γ 
values estimated based on the CV recorded for a gold electrode modified with NAC-DPTA-Cu(II)-rHis6-Jak2  
in the presence of 0.1 M KCl and  0.1 M CsCl. 
 
Electrolyte [ 0.1 M] α k [s
-1
] Γox. [mol×cm
-2
] Γred. [mol×cm
-2
] 
KCl 0.19 ± 0.09 1.36 ± 0.29 (1.59 ± 0.43) ×10
-10
 (1.56 ± 0.80) ×10
-10
 
CsCl 0.21 ± 0.08 1.06 ± 0.33 (1.81 ± 0.31) ×10
-10
 (1.86 ± 0.51) ×10
-10
 
 
 
 
 
 
 
 
 
 
 
Table 2.  The estimation of interactions strength between rHis6-Jak2 kinase and compounds studied based on 
relative decrease of Cu
II/I
 redox current measured at 0.05 and 0.20 μM  (n = 7-9). 
 
 
name 
of compound 
 
structure 
 
 
I0.05 μM/ Io x 
100% [%] 
I0.20 μM/ Io x 
100% [%] 
parameter ―b‖ 
of regression 
equation of 
relative Cu
II/I
 
current [%] 
vs. C in range: 
0.05–0.20 μM 
1 Erlotinib 
O
H3C
O
O
O
H3C
N
N
NH C
C
H
 
-35.84 ± 4.85 -51.72 ± 3.91 -31.4 
2 Fasudil N
N
H
S
O
ON
*HCl
 
-30.14 ± 9.15 -51.89 ± 9.47 -22.8 
3 Tasocitinib 
N
N
N
N
N
H
O
N
 
-19.97 ± 4.16 -32.24 ± 4.83 -17.2 
4 Lestaurtinib 
NN
N
H
O
O
OH
OH  
-16.37 ± 6.02 -44.18 ± 4.71 -9.2 
5 
Tyrphostin 
AG-490 
OH
OH
N
NH
O
 
-16.08 ± 2.65 -40.97 ±2.54 -9.1 
6 Berberine R8 
N
+
MeO
MeO
OMe
OMe
Cl
-
 
-13.55 ± 4.54 -31.48 ± 3.63 -8.3 
7 K252a 
N
N
H
N
O
O
H3C
MeOOC
H
OH  
-11.84 ± 4.51 -41.38 ± 7.40 -2.9 
8 Berberine R9 
Cl
-
N
+
MeO
MeO
OMe
OMe
 
-9.07 ± 3.43 -31.21 ± 6.78 -2.8 
9 Caffeic Acid 
OH
OH
OH
O
 
-1.31 ± 2.61 -16.25 ± 2.81 +3.44 
 
 
 
 
 
 
Fig. 1. Scheme of biosensor preparation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The cyclic voltammogram (CV) curves obtained for electrodes modified by NAC/DPTA-Cu(II) 
(solid line) and NAC/DPTA-Cu(II)-rGST-His6-JAK2 (dotted line). Measuring conditions: scan rate 100 
mV s
−1
, reference electrode Ag/AgCl, counter electrode Pt, solution composition: 0.1 M KCl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. OSWV voltammograms obtained for electrodes modified by NAC/DPTA-Cu(II) (solid line) and 
NAC/DPTA-Cu(II)-rGST-His6-JAK2 (dotted line). Measuring conditions: amplitude 50 mV, reference 
electrode Ag/AgCl, counter electrode Pt, solution composition: 0.1 M KCl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Cyclic voltammograms of rGST-His6-JAK2-Cu(II)-IDA/NAC-Au electrode measured at 
different scan rate. Scan rates: (a) 10 mV s
−1
, (b) 20 mV s
−1
, (c)30 mV s
−1
, (d) 40 mV s
−1
, (e) 50 mV s
−1
, 
(f) 100 mV s
−1
, (g) 200 mV s
−1
, (h)300 mV s
−1
, (i) 400 mV s
−1
, (j) 500 mV s
−1
, (k) 600 mV s
−1
, (l) 700 
mV s
−1
, (m) 800 mV s
−1
, (n) 900 mV s
−1
, (o) 1000 mV s
−1
. Measuring conditions: scan rates10–1000 mV 
s
−1
, reference electrode Ag/AgCl, counter electrode Pt. Solution composition: 0.1 M KCl. Inset: Plot of 
anodic (●, Ipa) and cathodic (■, Ipc) peak current against potential scan rates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Osteryoung square wave voltammetry (OSWV) recorded with gold electrode incorporated 
NAC/DPTA-Cu(II)-rGST-His6-JAK2 in the presence of: (A) Erlotinib, (B) Palmatine, (C) Caffeic Acid. 
Measuring conditions: scan rate 100 mV s
−1
, reference electrode Ag/AgCl, counter electrode Pt, solution 
composition: 0.1 M KCl. Concentration of Erlotinib: (a) 0.00 M, (b) 0.01 M, (c) 0.03 M, (d) 0.05 
M, (e) 0.10 M, (f) 0.15 M, (g) 0.20 M, (h) 0.30 M, (i) 0.40 M, (j) 0.50 M; concentration of 
caffeic acid and Palmatine: (a) 0.00 M, (b) 0.05 M, (c) 0.10 M, (d) 0.15 M, (e) 0.20 M,(f) 0.30 
M, (g) 0.40 M, (h) 0.50 M. 
 
 
 
Fig. 6. Relationships between the relative intensity of Cu(II) redox current vs. concentration of Erlotinib 
(diamonds), Palmatine (circles) and Caffeic Acid (squares). 
 
